⌘K

Home/Filings/4/A/0001104659-22-123807

4/A//SEC Filing

Alkon Daniel L. 4/A

Accession 0001104659-22-123807

CIK 0001571934other

View on SEC.gov Company Profile

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 7:53 PM ET

Size

5.1 KB

Accession

0001104659-22-123807

Insider Transaction Report

Form 4/AAmended

Period: 2021-07-13

Synaptogenix, Inc.SNPX

Alkon Daniel L.

DirectorChief Scientific Officer

Transactions

Award
Common Stock, par value $0.0001 per share
2021-07-13+43,750→ 55,234 total

Footnotes (1)

[F1]This filing amends the Form 4, filed on July 15, 2021 by Mr. Alkon to reflect the lower number of options allowed to be granted pursuant to the per-participant grant limit contained in the Issuer's 2020 Equity Incentive Plan, as amended.

Documents

1 file

4
tm2231816-7_4aseq1.xml
OWNERSHIP DOCUMENT

Issuer

Synaptogenix, Inc.

CIK 0001571934

Entity typeother

Related Parties

1

filerCIK 0001686138

Filing Metadata

Form type: 4/A
Filed: Nov 30, 7:00 PM ET
Accepted: Dec 1, 7:53 PM ET
Size: 5.1 KB

View on SEC.gov